Avadel pharmaceuticals provides corporate update and reports second quarter 2022 financial results

Dublin, ireland, aug. 09, 2022 (globe newswire) -- avadel pharmaceuticals plc (nasdaq: avdl), a biopharmaceutical company focused on transforming medicines to transform lives, today provided a corporate update and announced its financial results for the second quarter ended june 30, 2022.
AVDL Ratings Summary
AVDL Quant Ranking